Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – Even when patients with type 1 diabetes have excellent hemoglobin A1C levels, continuous glucose monitoring will be beneficial, according to a report in…
NEW YORK (Reuters Health) – Prehypertensive men who are physically fit are likely to live longer as a result, according to a long-term follow-up study published in the…
Chad Deal, MD, Rheumatologist, Head, Center for Osteoporosis and Metabolic Bone Disease, Cleveland Clinic, discusses denosumab, a new treatment for osteoporosis now being used to treat patients who…
Daniel Mazanec, MD, FACP, FACR, Associate Director, Center for Spine Health Cleveland Clinic, discusses medical acupuncture and its physiology. Summary: Acupuncture needling with electrical stimulation produces release of…
Daniel Mazanec, MD, FACP, FACR, Associate Director, Center for Spine Health Cleveland Clinic, discusses medical acupuncture and its role in western medicine treating headache, musculoskeletal disorders including osteoarthritis.…
NEW YORK (Reuters Health) – In trials of antimuscarinic agents for overactive bladder, the placebo responses tend to be large, statistically significant, and heterogeneous, according to a meta-analysis…
NEW YORK (Reuters Health) – New research suggests that the time it takes for an ambulance to transport a cardiac arrest patient from the field to the hospital…
NEW YORK (Reuters Health) – Using 30% rather than 90% oxygen to resuscitate extremely low gestational age neonates results in less oxidative stress, inflammation, and chronic lung disease,…
NEW YORK (Reuters Health) – Some modulators of 5-hydroxytryptamine (5-HT) appear to be effective in relieving symptoms of irritable bowel syndrome (IBS), the results of a systematic review…
NEW YORK (Reuters Health) Extended-duration treatment with the neuraminidase inhibitors (NAIs) oseltamivir or zanamivir can help prevent symptomatic influenza in immunocompetent adults, a review and analysis of trial…
